Showing results (161-170 of 183) with videos related to
Sort By:
Pageof 19
Journal of Crohn'S & Colitis|December 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic SignaturesMohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer, et al.Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2025
Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi StudyEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.The American Journal of Gastroenterology|January 9, 2023
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary CholangitisRozanne C de Veer, Maria C van Hooff, Christophe Corpechot, et al.Pageof 19